Arkansas has accused Eli Lilly And Co (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Sanofi SA (NASDAQ: SNY), and three of the largest pharmacy benefit managers (PBMs) of artificially...
Last week, Danish pharmaceutical company Novo Nordisk announced its first quarter earnings beating estimates, raising its growth outlook for the rest of 2022 and expanding its...
COPENHAGEN (Reuters) – Shares in Novo Nordisk jumped on Friday after the firm lifted its sales and operating profit guidance for the year on the back of forecast-beating...
Despite Wall Street’s ongoing bearish sentiment, new exchange-traded funds (ETF) have continued to reach the market in impressive numbers in 2022. ETFs listed in the US...
Exchange-traded funds (ETFs) have been gaining popularity in recent years and as investors' appetite grows for these investment instruments, asset managers are converting more and...
Reddit-hyped stocks slumpAlphabet, Amazon beat on earningsTech leads reflation trade rallyKey EventsUS futures contracts on the Dow, S&P, NASDAQ, and European stocks advanced...
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Sell | Strong Buy |
| Technical Indicators | Strong Sell | Strong Sell | Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 7.72 | 8.50 | 6.58 | +1.52 | +24.52% | 855.98K | Toronto | |||
| 2.96 | 3.00 | 2.65 | +0.220 | +8.03% | 144.84K | Toronto | |||
| 3.35 | 3.40 | 3.35 | 0.000 | 0.00% | 0.00 | Toronto | |||
| 0.27 | 0.28 | 0.27 | -0.01 | -1.82% | 38.00K | TSXV | |||
| 0.09 | 0.09 | 0.09 | 0.000 | 0.00% | 0.00 | Toronto | |||
| 2.02 | 2.05 | 2.01 | 0.000 | 0.00% | 1.17M | TSXV | |||
| 17.40 | 17.62 | 16.39 | +1.47 | +9.23% | 85.64K | NEO | |||
| 0.04 | 0.05 | 0.05 | 0.00 | 0.00% | 0.00 | NEO | |||
| 1.26 | 1.26 | 1.26 | 0.000 | 0.00% | 5.50K | Toronto | |||
| 0.55 | 0.55 | 0.55 | 0.00 | 0.00% | 0.00 | NEO | |||
| 0.09 | 0.10 | 0.08 | -0.01 | -5.56% | 171.97K | CSE | |||
| 0.30 | 0.31 | 0.31 | 0.00 | 0.00% | 0.00 | CSE | |||
| 4.02 | 4.10 | 3.90 | +0.07 | +1.77% | 54.30K | Toronto | |||
| 8.19 | 8.37 | 8.15 | +0.01 | +0.12% | 40.12K | Toronto | |||
| 0.105 | 0.12 | 0.105 | 0.000 | 0.00% | 45.36K | CSE |